Silicon Labs (NASDAQ: SLAB), a leading provider of silicon, software and solutions for a smarter, more connected world, today announced that the company will present at Stifel's 2019 Cross Sector...

Cognitive Clarity Inc., developers of the Percepta®, line of plant-based nootropics targeting brain plaques and tangles in the normal aging brain, today announced that its NSF-certified product,...

Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that a review of the...

New Zealand-based developer Ubiquitome will be exhibiting at the 2019 BIO International Convention in Philadelphia from 3 – 6 June. This event attracts 16,000+ attendees from over 7,000...

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that Daniel P. Gold, Ph.D., president and chief executive...

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that preliminary results from the dose escalation part of the phase 1 study with U3-1402, an investigational and potential...

Unisys Corporation (NYSE: UIS) today announced it will present at Fintech Americas 2019 to discuss the opportunities that embedded banking presents for the financial services industry, including...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Dean Schorno, the company's chief financial officer, is scheduled to present a company overview at the Jefferies 2019 Healthcare...

Researchers from Invitae (NYSE: NVTA), a leading medical genetics company, will present data that underscore the clinical utility of comprehensive genetic information for patients with breast,...

EIP Pharma, Inc., a CNS-focused therapeutics company, announced today that company management will present at two investor conferences in June. Jefferies 2019 Healthcare Conference Date: Friday,...